TD Cowen analyst Gary Taylor raised the firm’s price target on Agilon Health (AGL) to $6 from $3.50 and keeps a Hold rating on the shares. The firm updated its model as part of its 1Q25 Healthcare Facilities and Managed Care preview. Their FY25/26 adjusted EBITDA estimates are largely unchanged, but they tweaked quarterly cadences.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AGL:
- Balanced Outlook on Agilon Health: Hold Rating Amid Cautious Profitability and Conservative Revenue Growth
- Agilon Health price target lowered to $5 from $6 at Baird
- Agilon Health downgraded to Neutral from Outperform at Baird
- Agilon Health Stock (AGL) Rally’s Over 42% This Week on Analyst Upgrade
- Agilon Health rises 27.6%